> top > docs > PMC:7253482 > spans > 1856-2307 > annotations

PMC:7253482 / 1856-2307 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
67 325-330 Gene denotes spike Gene:43740568
76 12-22 Species denotes SARS-CoV-2 Tax:2697049
77 156-162 Species denotes humans Tax:9606
79 37-46 Disease denotes mortality MESH:D003643

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T10 335-343 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T10 12-20 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 12-16 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T10 156-162 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T11 312-317 http://purl.obolibrary.org/obo/CLO_0009985 denotes focus

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T10 335-343 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T8 265-274 http://purl.obolibrary.org/obo/IDO_0000528 denotes pathogens

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T282 0-8 RB denotes recently
T283 9-11 IN denotes of
T284 12-23 NN denotes SARS-CoV-24
T285 25-30 VBN denotes Given
T286 31-36 PRP-DOLLAR- denotes their
T287 37-46 NN denotes mortality
T288 47-52 NNS denotes rates
T289 52-53 -COMMA- denotes ,
T290 54-57 DT denotes the
T291 58-65 JJ denotes current
T292 66-70 NN denotes lack
T293 71-73 IN denotes of
T294 74-82 VBN denotes targeted
T295 83-93 NNS denotes treatments
T296 94-97 CC denotes and
T297 98-106 JJ denotes licensed
T298 107-115 NNS denotes vaccines
T299 115-116 -COMMA- denotes ,
T300 117-120 CC denotes and
T301 121-126 PRP-DOLLAR- denotes their
T302 127-135 NN denotes capacity
T303 136-138 TO denotes to
T304 139-147 VB denotes transmit
T305 148-155 IN denotes between
T306 156-162 NNS denotes humans
T307 163-166 CC denotes and
T308 167-173 IN denotes across
T309 174-181 NNS denotes species
T310 182-193 NN denotes barriers5,6
T311 193-194 -COMMA- denotes ,
T312 195-200 EX denotes there
T313 201-203 VBZ denotes is
T314 204-206 DT denotes an
T315 207-213 JJ denotes urgent
T316 214-218 NN denotes need
T317 219-222 IN denotes for
T318 223-232 JJ denotes effective
T319 233-248 NNS denotes countermeasures
T320 249-251 TO denotes to
T321 252-258 VB denotes combat
T322 259-264 DT denotes these
T323 265-274 NNS denotes pathogens
T324 276-283 VBG denotes Ongoing
T325 284-291 NN denotes vaccine
T326 292-303 NN denotes development
T327 304-311 NNS denotes efforts
T328 312-317 NN denotes focus
T329 318-320 IN denotes on
T330 321-324 DT denotes the
T331 325-330 NN denotes spike
T332 331-332 -LRB- denotes (
T333 332-333 NN denotes S
T334 333-334 -RRB- denotes )
T335 335-343 NNS denotes proteins
T336 344-348 WDT denotes that
T337 349-357 VBP denotes protrude
T338 358-362 IN denotes from
T339 363-366 DT denotes the
T340 367-372 JJ denotes viral
T341 373-381 NN denotes envelope
T342 382-385 CC denotes and
T343 386-396 VB denotes constitute
T344 397-400 DT denotes the
T345 401-405 JJ denotes main
T346 406-412 NN denotes target
T347 413-415 IN denotes of
T348 416-428 VBG denotes neutralizing
T349 429-442 NN denotes antibodies7,8
T350 444-449 DT denotes These
R277 T283 T282 arg1Of of,recently
R279 T284 T283 arg2Of SARS-CoV-24,of
R280 T313 T285 arg1Of is,Given
R281 T300 T285 arg2Of and,Given
R282 T288 T286 arg1Of rates,their
R283 T288 T287 arg1Of rates,mortality
R284 T288 T289 arg1Of rates,","
R285 T292 T289 arg2Of lack,","
R286 T292 T290 arg1Of lack,the
R287 T292 T291 arg1Of lack,current
R288 T292 T293 arg1Of lack,of
R289 T296 T293 arg2Of and,of
R290 T295 T294 arg2Of treatments,targeted
R291 T295 T296 arg1Of treatments,and
R292 T298 T296 arg2Of vaccines,and
R293 T298 T297 arg1Of vaccines,licensed
R294 T300 T299 arg1Of and,","
R295 T289 T300 arg1Of ",",and
R296 T302 T300 arg2Of capacity,and
R297 T302 T301 arg1Of capacity,their
R298 T304 T303 arg1Of transmit,to
R299 T302 T303 modOf capacity,to
R300 T304 T305 arg1Of transmit,between
R301 T306 T305 arg2Of humans,between
R302 T285 T307 arg1Of Given,and
R303 T308 T307 arg2Of across,and
R304 T313 T308 arg1Of is,across
R305 T310 T308 arg2Of "barriers5,6",across
R306 T310 T309 arg1Of "barriers5,6",species
R307 T313 T311 arg1Of is,","
R308 T312 T313 arg1Of there,is
R309 T316 T313 arg2Of need,is
R310 T316 T314 arg1Of need,an
R311 T316 T315 arg1Of need,urgent
R312 T316 T317 arg1Of need,for
R313 T319 T317 arg2Of countermeasures,for
R314 T321 T317 arg3Of combat,for
R315 T319 T318 arg1Of countermeasures,effective
R316 T321 T320 arg1Of combat,to
R317 T319 T321 arg1Of countermeasures,combat
R318 T323 T321 arg2Of pathogens,combat
R319 T323 T322 arg1Of pathogens,these
R320 T328 T324 arg1Of focus,Ongoing
R321 T328 T325 arg1Of focus,vaccine
R322 T328 T326 arg1Of focus,development
R323 T328 T327 arg1Of focus,efforts
R324 T328 T329 arg1Of focus,on
R325 T335 T329 arg2Of proteins,on
R326 T335 T330 arg1Of proteins,the
R327 T335 T331 arg1Of proteins,spike
R328 T335 T332 arg1Of proteins,(
R329 T333 T332 arg2Of S,(
R330 T334 T332 arg3Of ),(
R331 T335 T336 arg1Of proteins,that
R332 T335 T337 arg1Of proteins,protrude
R333 T337 T338 arg1Of protrude,from
R334 T341 T338 arg2Of envelope,from
R335 T341 T339 arg1Of envelope,the
R336 T341 T340 arg1Of envelope,viral
R337 T337 T342 arg1Of protrude,and
R338 T343 T342 arg2Of constitute,and
R339 T335 T343 arg1Of proteins,constitute
R340 T346 T343 arg2Of target,constitute
R341 T346 T344 arg1Of target,the
R342 T346 T345 arg1Of target,main
R343 T346 T347 arg1Of target,of
R344 T348 T347 arg2Of neutralizing,of
R345 T349 T348 arg2Of "antibodies7,8",neutralizing

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T10 335-343 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T10 335-343 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T17 12-20 Species denotes SARS-CoV NCBItxid:694009
T18 12-16 Species denotes SARS NCBItxid:694009
T19 156-162 Species denotes humans NCBItxid:9605

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T14 25-275 Sentence denotes Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens.
T15 276-443 Sentence denotes Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T10 12-20 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 12-16 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
76 12-22 Species denotes SARS-CoV-2 Tax:2697049
79 37-46 Disease denotes mortality MESH:D003643
77 156-162 Species denotes humans Tax:9606
67 325-330 Gene denotes spike Gene:43740568

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T714 331-343 Protein denotes (S) proteins https://www.uniprot.org/uniprot/Q9UIP0|https://www.uniprot.org/uniprot/Q9UIN9|https://www.uniprot.org/uniprot/Q9UIN8|https://www.uniprot.org/uniprot/Q9UIN7|https://www.uniprot.org/uniprot/Q9UIN6|https://www.uniprot.org/uniprot/Q9UBH8|https://www.uniprot.org/uniprot/Q9NRH8|https://www.uniprot.org/uniprot/Q9NRH7|https://www.uniprot.org/uniprot/Q9NRH6|https://www.uniprot.org/uniprot/Q9NRH5|https://www.uniprot.org/uniprot/Q9NRH4|https://www.uniprot.org/uniprot/Q9NPG5|https://www.uniprot.org/uniprot/Q9NPE0|https://www.uniprot.org/uniprot/Q9NP52|https://www.uniprot.org/uniprot/Q95IF9|https://www.uniprot.org/uniprot/Q8N5P3|https://www.uniprot.org/uniprot/Q8IZU6|https://www.uniprot.org/uniprot/Q8IZU5|https://www.uniprot.org/uniprot/Q8IZU4|https://www.uniprot.org/uniprot/Q86Z04|https://www.uniprot.org/uniprot/Q7YR44|https://www.uniprot.org/uniprot/Q7LA71|https://www.uniprot.org/uniprot/Q7LA70|https://www.uniprot.org/uniprot/Q5STD2|https://www.uniprot.org/uniprot/Q5SQ85|https://www.uniprot.org/uniprot/Q1XI16|https://www.uniprot.org/uniprot/Q1XI12|https://www.uniprot.org/uniprot/Q15517|https://www.uniprot.org/uniprot/O43509|https://www.uniprot.org/uniprot/O19084|https://www.uniprot.org/uniprot/B0UYZ7|https://www.uniprot.org/uniprot/B0S7V2|https://www.uniprot.org/uniprot/A5A6L9

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T14 25-275 Sentence denotes Given their mortality rates, the current lack of targeted treatments and licensed vaccines, and their capacity to transmit between humans and across species barriers5,6, there is an urgent need for effective countermeasures to combat these pathogens.
T15 276-443 Sentence denotes Ongoing vaccine development efforts focus on the spike (S) proteins that protrude from the viral envelope and constitute the main target of neutralizing antibodies7,8.